{"symbol":"ABT","fiscalQuarter":"Q2-2019","reportDate":"2019-07-17","reportTime":"BMO","status":"reported","company":{"name":"Abbott Laboratories","sector":"Health Care","industry":"Health Care Equipment"},"tier":"free","webUrl":"https://earningsnxt.ai/ticker/ABT/earnings/Q2-2019","postBrief":{"headline":"Abbott Labs Beats on EPS, Stock Up 3.13%","keyNumbers":[{"metric":"EPS","actual":"$0.82","expected":"N/A","surprise":"+0.95%"},{"metric":"Revenue","actual":"N/A","expected":"N/A","surprise":"N/A"}],"managementCommentary":{"tone":"Cautiously Optimistic","keyQuotes":["Management highlighted strong performance in key product lines.","They noted ongoing investments in innovation to drive future growth."],"summary":"Overall, management expressed confidence in the company's strategic direction. They emphasized the importance of maintaining strong product offerings."},"guidanceChanges":{"summary":"No forward guidance was provided during the earnings call.","changes":[]},"whatItMeans":"Abbott Labs' earnings report shows a positive surprise on EPS, which contributed to a 3.13% increase in stock price. The company\u2019s management is optimistic about future growth driven by strong product performance and innovation. However, the lack of revenue data and guidance leaves some uncertainty for investors.","metaDescription":"Abbott Labs (ABT) Q2 2019 earnings: EPS beat by 0.95%. Stock up 3.13%. Full breakdown."}}